Cargando…

Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases

Background: The term “uterine smooth muscle tumor of uncertain malignant potential” (STUMP) indicates a rare tumor that cannot be classified as a benign leiomyoma or malignant leiomyosarcoma. In this study, we assessed the clinical characteristics, fertility, and oncologic outcomes of patients diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Lanqing, Wang, Dan, Wang, Wenze, Cao, Dongyan, Yang, Jiaxin, Wu, Ming, Yang, Junjun, Xiang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240040/
https://www.ncbi.nlm.nih.gov/pubmed/32477938
http://dx.doi.org/10.3389/fonc.2020.00647
_version_ 1783536801108983808
author Huo, Lanqing
Wang, Dan
Wang, Wenze
Cao, Dongyan
Yang, Jiaxin
Wu, Ming
Yang, Junjun
Xiang, Yang
author_facet Huo, Lanqing
Wang, Dan
Wang, Wenze
Cao, Dongyan
Yang, Jiaxin
Wu, Ming
Yang, Junjun
Xiang, Yang
author_sort Huo, Lanqing
collection PubMed
description Background: The term “uterine smooth muscle tumor of uncertain malignant potential” (STUMP) indicates a rare tumor that cannot be classified as a benign leiomyoma or malignant leiomyosarcoma. In this study, we assessed the clinical characteristics, fertility, and oncologic outcomes of patients diagnosed as STUMP in 14 years. In addition, we analyzed the risk factors for recurrence in patients with STUMP. Methods: Medical records of STUMP patients at Peking Union Medical College Hospital (PUMCH) between January 2005 and June 2019 were reviewed and analyzed. Disease-free survival, age of diagnosis, tumor size, surgical procedure, pathology and immunohistochemistry, clinical characteristics, recurrence rate, and reproductive outcomes in the follow-up period were assessed. Univariate and multivariate analyses were performed to determine the prognostic factors. Results: The median age was 42 years old (range: 21–63). Total hysterectomy with or without bilateral salpingo-oophorectomy was performed in 29/67 cases (43.3%), and myomectomy was performed in 38/67 cases (56.7%). Ten patients experienced recurrences, and all but two recurrences occurred within 5 years after the initial surgery. Only two of these recurrences were leiomyosarcoma. There were no deaths in the median follow-up period of 48.4 (range 2.6–170.2) months. There were no remarkable differences in location of tumor between the myomectomy and hysterectomy groups, but the patients in the myomectomy group were younger than those in the hysterectomy group. In univariate and multivariate analysis, mitosis on pathology was the only independent risk factor for recurrence. Expression of Ki-67, p53, and p16 was significantly higher in patients with recurrence. Seven of the 35 patients who attempted to conceive had successful pregnancies. Conclusions: The prognosis of STUMP was favorable and tumors with more than 10 mitoses per 10 high power field should be monitored closely. The surgical procedure was not an independent risk factor of recurrence, and myomectomy may be an acceptable option for patients wishing to preserve fertility.
format Online
Article
Text
id pubmed-7240040
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72400402020-05-29 Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases Huo, Lanqing Wang, Dan Wang, Wenze Cao, Dongyan Yang, Jiaxin Wu, Ming Yang, Junjun Xiang, Yang Front Oncol Oncology Background: The term “uterine smooth muscle tumor of uncertain malignant potential” (STUMP) indicates a rare tumor that cannot be classified as a benign leiomyoma or malignant leiomyosarcoma. In this study, we assessed the clinical characteristics, fertility, and oncologic outcomes of patients diagnosed as STUMP in 14 years. In addition, we analyzed the risk factors for recurrence in patients with STUMP. Methods: Medical records of STUMP patients at Peking Union Medical College Hospital (PUMCH) between January 2005 and June 2019 were reviewed and analyzed. Disease-free survival, age of diagnosis, tumor size, surgical procedure, pathology and immunohistochemistry, clinical characteristics, recurrence rate, and reproductive outcomes in the follow-up period were assessed. Univariate and multivariate analyses were performed to determine the prognostic factors. Results: The median age was 42 years old (range: 21–63). Total hysterectomy with or without bilateral salpingo-oophorectomy was performed in 29/67 cases (43.3%), and myomectomy was performed in 38/67 cases (56.7%). Ten patients experienced recurrences, and all but two recurrences occurred within 5 years after the initial surgery. Only two of these recurrences were leiomyosarcoma. There were no deaths in the median follow-up period of 48.4 (range 2.6–170.2) months. There were no remarkable differences in location of tumor between the myomectomy and hysterectomy groups, but the patients in the myomectomy group were younger than those in the hysterectomy group. In univariate and multivariate analysis, mitosis on pathology was the only independent risk factor for recurrence. Expression of Ki-67, p53, and p16 was significantly higher in patients with recurrence. Seven of the 35 patients who attempted to conceive had successful pregnancies. Conclusions: The prognosis of STUMP was favorable and tumors with more than 10 mitoses per 10 high power field should be monitored closely. The surgical procedure was not an independent risk factor of recurrence, and myomectomy may be an acceptable option for patients wishing to preserve fertility. Frontiers Media S.A. 2020-05-14 /pmc/articles/PMC7240040/ /pubmed/32477938 http://dx.doi.org/10.3389/fonc.2020.00647 Text en Copyright © 2020 Huo, Wang, Wang, Cao, Yang, Wu, Yang and Xiang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Huo, Lanqing
Wang, Dan
Wang, Wenze
Cao, Dongyan
Yang, Jiaxin
Wu, Ming
Yang, Junjun
Xiang, Yang
Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases
title Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases
title_full Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases
title_fullStr Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases
title_full_unstemmed Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases
title_short Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases
title_sort oncologic and reproductive outcomes of uterine smooth muscle tumor of uncertain malignant potential: a single center retrospective study of 67 cases
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240040/
https://www.ncbi.nlm.nih.gov/pubmed/32477938
http://dx.doi.org/10.3389/fonc.2020.00647
work_keys_str_mv AT huolanqing oncologicandreproductiveoutcomesofuterinesmoothmuscletumorofuncertainmalignantpotentialasinglecenterretrospectivestudyof67cases
AT wangdan oncologicandreproductiveoutcomesofuterinesmoothmuscletumorofuncertainmalignantpotentialasinglecenterretrospectivestudyof67cases
AT wangwenze oncologicandreproductiveoutcomesofuterinesmoothmuscletumorofuncertainmalignantpotentialasinglecenterretrospectivestudyof67cases
AT caodongyan oncologicandreproductiveoutcomesofuterinesmoothmuscletumorofuncertainmalignantpotentialasinglecenterretrospectivestudyof67cases
AT yangjiaxin oncologicandreproductiveoutcomesofuterinesmoothmuscletumorofuncertainmalignantpotentialasinglecenterretrospectivestudyof67cases
AT wuming oncologicandreproductiveoutcomesofuterinesmoothmuscletumorofuncertainmalignantpotentialasinglecenterretrospectivestudyof67cases
AT yangjunjun oncologicandreproductiveoutcomesofuterinesmoothmuscletumorofuncertainmalignantpotentialasinglecenterretrospectivestudyof67cases
AT xiangyang oncologicandreproductiveoutcomesofuterinesmoothmuscletumorofuncertainmalignantpotentialasinglecenterretrospectivestudyof67cases